Follow Us:
Sunday, July 25, 2021

PM Modi to visit Pune’s Serum Institute of India on Saturday

In view of this, a 'familiarisation visit' to Pune of foreign ambassadors and high commissioners on November 27 has been postponed to December 4.

By: Express News Service | Pune |
Updated: November 26, 2020 11:10:55 pm
PM Narendra Modi

Prime Minister Narendra Modi will visit the Serum Institute of India (SII) in Pune on Saturday to ‘understand the process of vaccine production and distribution’. Local administration officials in Pune said they have received confirmation about the Prime Minister’s visit.

Pune Divisional Commissioner Saurabh Rao said, “The Prime Minister’s visit to Pune has been confirmed and he will visit the Serum Institute.” Modi will arrive at Pune around 1 pm and leave around 2.30 pm on Saturday, as per the tentative schedule, said officials.

Senior administration and police officials have already started preparing the groundwork for the visit. Preparatory meetings between district administration officials, police, Serum Institute office-bearers and central government entities were held on Thursday also.

A ‘familiarisation visit’ of Foreign Ambassadors and High Commissioners based in New Delhi to Pune has also been scheduled for December 4.

“Ambassadors and High Commissioners from nearly 100 countries are slated to come to Pune on December 4. The Ambassadors and High Commissioners will visit both Serum Institute and Gennova Biopharmaceuticals,” said Rao.

As per the official programme of the Foreign Ambassadors and High Commissioners, they will arrive at Pune around 10 am on December 4, and will visit the Serum Institute and Gennova Biopharmaceuticals in two alternate groups.

Earlier this week, Adar Poonawalla, CEO of Serum Institute, had told The Indian Express in an email response that Phase 3 trials of the Covishield vaccine were underway and while UK trial results have been released, they expect the data on the Indian trials to be out within a month.

Pune-based Gennova Biopharmaceuticals is all set to start Phase 1 human clinical trials of its Covid-19 vaccine candidate. After Moderna and Pfizer, Gennova Biopharmaceuticals is the only Indian company that has worked on making a mRNA-based Covid vaccine. The first two Covid-19 vaccines to announce Phase 3 results were mRNA-based.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest India News, download Indian Express App.

  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by